1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
DeRose, E.F.
Clarkson, M.W.
Gilmore, S.A.
Ramsden, D.A.
Mueller, G.A.
London, R.E.
Lee, A.L.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
46
12100
12110
10.1021/bi7007728
17915942
Solution structure of polymerase mu's BRCT Domain reveals an element essential for its role in nonhomologous end joining.
2007
10.2210/pdb2htf/pdb
pdb_00002htf
1
SINGLE WAVELENGTH
M
1
1.0
11420.022
DNA polymerase mu
2.7.7.7
BRCT domain
S20G
1
man
polymer
Pol Mu
no
no
GTPPSTRFPGVAIYLVEPRMGRSRRAFLTGLARSKGFRVLDACSSEATHVVMEETSAEEAVSWQERRMAAAPPGCTPPAL
LDISWLTESLGAGQPVPVECRHRLE
GTPPSTRFPGVAIYLVEPRMGRSRRAFLTGLARSKGFRVLDACSSEATHVVMEETSAEEAVSWQERRMAAAPPGCTPPAL
LDISWLTESLGAGQPVPVECRHRLE
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
sample
POLM
9606
Homo sapiens
562
Escherichia coli
database_2
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
1
0
2007-02-27
1
1
2008-05-01
1
2
2011-07-13
1
3
2022-03-09
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_struct_ref_seq_dif.details
RCSB
Y
RCSB
2006-07-25
REL
REL
structures with the lowest energy
100
11
3D_13C-separated_NOESY
3D_15N-separated_NOESY
50 mM KCl
7.9
ambient
283
K
The initial structures were computed using the auto noeassign feature of CYANA 2.1; 1503 NOE distance restraints were assigned, and 147 dihedral angle restraints were used in the calculation. The 20 best CYANA structures were refined in explicit solvent using ARIA 2.0a with the 1506 NOE distance restraints, 147 dihedral angle restraints, 42 H-bond restraints, and 48 residual dipolar coupling restraints.
Torsion angle dynamics followed by molecular dynamics refinement in explicit water solvent
1
minimized average structure
1mM polymerase mu BRCT domain, 25 mM d-Tris, 50 mM KCl, 0.02% NaN3, 5 mM DTT, pH 7.9, 90% H2O, 10% D2O
90% H2O/10% D2O
Varian
collection
VNMR
1.1C, VNMRJ 1.1C
Delaglio, Grzesiek, Vuister, Zhu, Pfeifer, and Bax
processing
NMRPipe
2003, 2004
Johnson and Blevins
processing
NMRView
5.0.4
Guentert, Mumenthaler, Herrmann, and Wuthrich
structure solution
CYANA
2.1
Habeck, Rieping, Linge, and Nilges
refinement
ARIA
2.0a
600
Varian
INOVA
800
Varian
INOVA
GLY
20
n
1
GLY
20
A
THR
21
n
2
THR
21
A
PRO
22
n
3
PRO
22
A
PRO
23
n
4
PRO
23
A
SER
24
n
5
SER
24
A
THR
25
n
6
THR
25
A
ARG
26
n
7
ARG
26
A
PHE
27
n
8
PHE
27
A
PRO
28
n
9
PRO
28
A
GLY
29
n
10
GLY
29
A
VAL
30
n
11
VAL
30
A
ALA
31
n
12
ALA
31
A
ILE
32
n
13
ILE
32
A
TYR
33
n
14
TYR
33
A
LEU
34
n
15
LEU
34
A
VAL
35
n
16
VAL
35
A
GLU
36
n
17
GLU
36
A
PRO
37
n
18
PRO
37
A
ARG
38
n
19
ARG
38
A
MET
39
n
20
MET
39
A
GLY
40
n
21
GLY
40
A
ARG
41
n
22
ARG
41
A
SER
42
n
23
SER
42
A
ARG
43
n
24
ARG
43
A
ARG
44
n
25
ARG
44
A
ALA
45
n
26
ALA
45
A
PHE
46
n
27
PHE
46
A
LEU
47
n
28
LEU
47
A
THR
48
n
29
THR
48
A
GLY
49
n
30
GLY
49
A
LEU
50
n
31
LEU
50
A
ALA
51
n
32
ALA
51
A
ARG
52
n
33
ARG
52
A
SER
53
n
34
SER
53
A
LYS
54
n
35
LYS
54
A
GLY
55
n
36
GLY
55
A
PHE
56
n
37
PHE
56
A
ARG
57
n
38
ARG
57
A
VAL
58
n
39
VAL
58
A
LEU
59
n
40
LEU
59
A
ASP
60
n
41
ASP
60
A
ALA
61
n
42
ALA
61
A
CYS
62
n
43
CYS
62
A
SER
63
n
44
SER
63
A
SER
64
n
45
SER
64
A
GLU
65
n
46
GLU
65
A
ALA
66
n
47
ALA
66
A
THR
67
n
48
THR
67
A
HIS
68
n
49
HIS
68
A
VAL
69
n
50
VAL
69
A
VAL
70
n
51
VAL
70
A
MET
71
n
52
MET
71
A
GLU
72
n
53
GLU
72
A
GLU
73
n
54
GLU
73
A
THR
74
n
55
THR
74
A
SER
75
n
56
SER
75
A
ALA
76
n
57
ALA
76
A
GLU
77
n
58
GLU
77
A
GLU
78
n
59
GLU
78
A
ALA
79
n
60
ALA
79
A
VAL
80
n
61
VAL
80
A
SER
81
n
62
SER
81
A
TRP
82
n
63
TRP
82
A
GLN
83
n
64
GLN
83
A
GLU
84
n
65
GLU
84
A
ARG
85
n
66
ARG
85
A
ARG
86
n
67
ARG
86
A
MET
87
n
68
MET
87
A
ALA
88
n
69
ALA
88
A
ALA
89
n
70
ALA
89
A
ALA
90
n
71
ALA
90
A
PRO
91
n
72
PRO
91
A
PRO
92
n
73
PRO
92
A
GLY
93
n
74
GLY
93
A
CYS
94
n
75
CYS
94
A
THR
95
n
76
THR
95
A
PRO
96
n
77
PRO
96
A
PRO
97
n
78
PRO
97
A
ALA
98
n
79
ALA
98
A
LEU
99
n
80
LEU
99
A
LEU
100
n
81
LEU
100
A
ASP
101
n
82
ASP
101
A
ILE
102
n
83
ILE
102
A
SER
103
n
84
SER
103
A
TRP
104
n
85
TRP
104
A
LEU
105
n
86
LEU
105
A
THR
106
n
87
THR
106
A
GLU
107
n
88
GLU
107
A
SER
108
n
89
SER
108
A
LEU
109
n
90
LEU
109
A
GLY
110
n
91
GLY
110
A
ALA
111
n
92
ALA
111
A
GLY
112
n
93
GLY
112
A
GLN
113
n
94
GLN
113
A
PRO
114
n
95
PRO
114
A
VAL
115
n
96
VAL
115
A
PRO
116
n
97
PRO
116
A
VAL
117
n
98
VAL
117
A
GLU
118
n
99
GLU
118
A
CYS
119
n
100
CYS
119
A
ARG
120
n
101
ARG
120
A
HIS
121
n
102
HIS
121
A
ARG
122
n
103
ARG
122
A
LEU
123
n
104
LEU
123
A
GLU
124
n
105
GLU
124
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
ARG
57
A
O
ARG
38
A
N
ILE
32
A
N
ILE
13
A
N
TYR
33
A
N
TYR
14
A
O
HIS
68
A
O
HIS
49
A
N
VAL
69
A
N
VAL
50
A
O
LEU
100
A
O
LEU
81
2
A
A
HB3
HA
LEU
ARG
100
122
1.18
2
A
A
HG13
HE1
VAL
TRP
69
82
1.25
2
A
A
O
H
ARG
GLU
122
124
1.60
3
A
A
O
H
LEU
ALA
47
51
1.55
4
A
A
HB
HA
THR
ARG
25
57
1.30
5
A
A
HB
HB2
THR
ARG
25
57
1.27
6
A
A
HD1
HD12
HIS
LEU
68
100
1.17
7
A
A
HG13
HE1
VAL
TRP
69
82
1.23
8
A
A
HG13
HE1
VAL
TRP
69
82
1.20
8
A
A
HG
HB2
LEU
ALA
59
66
1.30
8
A
A
HB
HA
THR
ARG
25
57
1.35
9
A
A
HG13
HE1
VAL
TRP
69
82
1.28
10
A
A
HB
HB2
THR
ARG
25
57
1.28
11
A
A
HG13
HE1
VAL
TRP
69
82
1.23
1
A
SER
24
-59.49
86.93
1
A
ARG
26
61.89
-82.23
1
A
PRO
28
-71.24
-167.47
1
A
ALA
61
62.96
166.37
1
A
ALA
76
-60.64
-73.09
1
A
PRO
92
-55.71
106.27
1
A
PRO
97
-69.52
-179.50
1
A
PRO
114
-63.74
93.53
1
A
LEU
123
-72.24
22.93
2
A
PRO
23
-53.49
87.71
2
A
PRO
28
-77.25
49.95
2
A
PRO
37
-68.93
9.13
2
A
ARG
38
-149.38
36.27
2
A
LYS
54
-93.29
-60.76
2
A
HIS
68
169.77
100.57
2
A
PRO
97
-77.44
-167.70
2
A
LEU
123
48.79
-25.39
3
A
PRO
23
-67.50
66.45
3
A
THR
25
-122.41
-120.81
3
A
ARG
26
-178.82
-69.10
3
A
PRO
37
-71.58
46.68
3
A
ARG
38
-174.09
-45.88
3
A
MET
39
-83.15
-71.48
3
A
ASP
60
-109.76
-161.84
3
A
ILE
102
-58.27
-1.17
3
A
PRO
114
-68.10
95.13
3
A
ARG
122
-86.67
33.26
3
A
LEU
123
-56.44
6.67
4
A
PRO
23
-40.07
102.29
4
A
ARG
26
77.22
-55.34
4
A
PRO
28
-84.02
-159.09
4
A
MET
39
-171.17
128.60
4
A
LYS
54
-96.60
-62.16
4
A
ASP
60
-86.31
39.23
4
A
PRO
97
-64.98
-166.23
4
A
LEU
100
170.98
155.71
4
A
ARG
122
-79.05
31.87
4
A
LEU
123
-62.37
15.93
5
A
PRO
23
-69.55
63.28
5
A
ARG
26
-115.01
-78.59
5
A
ARG
38
-141.18
43.75
5
A
CYS
62
75.70
-36.97
5
A
HIS
68
-161.59
105.87
5
A
LEU
100
-172.80
-175.02
5
A
PRO
114
-66.82
95.31
6
A
PRO
37
-74.47
49.15
6
A
ARG
38
-175.13
-40.90
6
A
HIS
68
157.22
91.55
6
A
LEU
100
-172.26
-167.42
6
A
ASP
101
-119.15
-165.04
6
A
ARG
122
-86.18
34.56
6
A
LEU
123
-60.83
6.38
7
A
ARG
26
-103.43
-60.21
7
A
MET
39
-172.44
-166.43
7
A
PRO
114
-64.60
90.80
7
A
LEU
123
63.24
-70.13
8
A
PRO
23
-55.52
105.51
8
A
THR
25
-128.06
-92.62
8
A
ARG
26
164.28
-70.24
8
A
ASP
60
-78.97
-143.47
8
A
CYS
62
58.44
73.62
8
A
PRO
97
-60.33
-160.77
8
A
ILE
102
-58.38
-6.44
8
A
LEU
123
-52.76
83.09
9
A
PRO
23
-66.03
63.74
9
A
LYS
54
-90.31
-62.21
9
A
ASP
60
-77.61
-169.78
9
A
THR
67
-156.76
55.12
9
A
HIS
68
157.88
95.51
9
A
PRO
97
-58.13
-154.67
9
A
LEU
100
174.26
-167.72
9
A
PRO
114
-65.22
92.26
9
A
LEU
123
-49.98
-5.99
10
A
PRO
23
-38.03
99.03
10
A
ARG
26
89.30
-45.13
10
A
ARG
38
69.03
-11.11
10
A
CYS
62
74.37
-45.17
10
A
PRO
97
-62.58
-175.10
10
A
ILE
102
-65.66
55.27
10
A
SER
103
-131.20
-31.20
10
A
PRO
114
-67.49
99.85
10
A
ARG
122
-83.42
32.70
10
A
LEU
123
-61.46
24.13
11
A
PRO
23
-38.26
116.81
11
A
THR
25
50.77
70.75
11
A
ASP
60
-149.08
38.91
11
A
THR
67
-155.26
42.69
11
A
HIS
68
163.95
67.63
11
A
PRO
97
-62.67
-159.22
11
A
LEU
100
-172.69
-172.41
11
A
PRO
114
-67.76
84.99
minimized average
The solution structure of the BRCT domain from human polymerase reveals homology with the TdT BRCT domain
1
N
N
A
GLU
36
A
GLU
17
HELX_P
A
MET
39
A
MET
20
5
1
4
A
GLY
40
A
GLY
21
HELX_P
A
GLY
55
A
GLY
36
1
2
16
A
SER
75
A
SER
56
HELX_P
A
ALA
90
A
ALA
71
1
3
16
A
ILE
102
A
ILE
83
HELX_P
A
GLY
112
A
GLY
93
1
4
11
TRANSFERASE
BRCT domain, alpha-beta-alpha sandwich, TRANSFERASE
DPOLM_HUMAN
UNP
1
20
Q9NP87
STPPSTRFPGVAIYLVEPRMGRSRRAFLTGLARSKGFRVLDACSSEATHVVMEETSAEEAVSWQERRMAAAPPGCTPPAL
LDISWLTESLGAGQPVPVECRHRLE
21
124
2HTF
21
124
Q9NP87
A
1
2
105
1
cloning artifact
GLY
20
2HTF
A
Q9NP87
UNP
1
4
parallel
parallel
parallel
A
ARG
57
A
ARG
38
A
LEU
59
A
LEU
40
A
ALA
31
A
ALA
12
A
LEU
34
A
LEU
15
A
HIS
68
A
HIS
49
A
MET
71
A
MET
52
A
ALA
98
A
ALA
79
A
ASP
101
A
ASP
82
1
P 1